Whether it’s diet, exercise or air pollution, researchers are constantly investigating lifestyle and environmental factors that may play a role in the progression or…
The U.S. Food and Drug Administration (FDA) has approved a re-dosing study for patients formerly enrolled in Biogen’s phase three clinical trials of its…
A recent study conducted by the Virginia Tech Helmet Lab dug into a growing concern among sports fans: Youth football players are more vulnerable…
Air pollution has been associated with a myriad of chronic health conditions, from asthma to cancer. It’s now believed to also increase the risk…
Research into Alzheimer’s detection has looked into a variety of possibilities, from blood tests to expensive and extensive brain scanning. But some researchers have…
The study was in mice and the findings are still very preliminary, but researchers at Case Western University School of Medicine have identified a…
Being Patient spoke with Dr. Peter Snyder about his research into retinal scanning technology that may be able to identify markers of Alzheimer’s disease,…
Soybean oil — a vegetable oil made from soybean seeds — is one of the most popular types of oils consumed in the U.S.,…
Decades ago, a chaperone was a person who accompanied an unmarried girl in public. Now, however, we’re learning that a chaperone — in this…
A new study by Houston Methodist scientists finds that a protein linked to ovarian cancer may contribute to the development of Alzheimer’s disease. The…
In a new study, scientists have tested an experimental drug in mice that may hold promise for future Alzheimer’s treatments. The drug involves a…
Early detection of dementia and Alzheimer’s disease can help patients get the care and help they need sooner rather than later, but there is…
The well-known factors that contribute to the development of dementia include genetics, age, lifestyle and even environment. But more and more research is pointing…
While scientists remain far from finding a cure for dementia in its many forms, researchers are continuing to make slow-but-steady progress toward identifying potential…
Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…